Earnings6 reported quarters · next on Jan 26, 2027
Earnings
Quarter
EPS
EPS expected
Revenue
Revenue expected
Result
Q2 FY2027reported Oct 27, 2026
$1.38
$1.25
$312.4M
$310.4M
EPS beatRevenue in line
Q1 FY2027reported Jul 28, 2026
$1.42
$1.16
$314.1M
$310.4M
EPS beatRevenue in line
Q4 FY2026reported Apr 28, 2026
$1.28
$1.09
$311.7M
$306.7M
EPS beatRevenue beat
Q3 FY2026reported Jan 27, 2026
$1.17
$0.98
$313.8M
$299.1M
EPS beatRevenue beat
Q2 FY2026reported Oct 28, 2025
$0.91
$0.94
$276.2M
$273.3M
EPS missRevenue in line
Q1 FY2026reported Jul 29, 2025
$1.01
$0.97
$282.0M
$268.0M
EPS beatRevenue beat
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Firms' latest targets on CVLT range from $170 to $210.
Lowest: Jefferies, Oct 25Highest: D.A. Davidson, Oct 28
Past year Each firm's latest target, newest first
Each firm's latest price target on CVLT, newest first
Firm
Rating
Target
Action
Date
Mizuho
Outperform
$200
Maintained
D.A. Davidson
Buy
$210
Raised from $175
RBC Capital
Sector Perform
$180
Raised from $160
Scotiabank
Sector Perform
$180
Raised from $160
Wells Fargo
Overweight
$185
Target set
Truist Securities
Buy
$200
Raised from $182
Stephens
Not stated
$205
Target set
Jefferies
Hold
$170
Raised from $130
Piper Sandler
Neutral
$133
Target set
Cantor Fitzgerald
Neutralrated Oct 26, 2026
$132
Raised from $100
KeyBanc
Overweight
$175
Raised from $125
Oppenheimer
Outperform
$150
Cut from $180
Baird
Not stated
$185
Target set
Guggenheim
Buy
$175
Cut from $200
Each firm's latest target from the past year, with the rating stated with its note or within three days of it. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.
The range is each listed firm's latest target from the last 90 days, lowest to highest. It is not an average. 1 other firm rated CVLT in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 16, 2026.
Proxy statementas filed for fiscal 2026 · proxy filed Jun 24, 2026
Executive pay
Sanjay Mirchandani’s pay as CEO came to $19.9M for fiscal 2026.
Executive
Salary
Stock awards
Other
Total
Sanjay MirchandaniPresident and CEO
$694K
$18.0M
$1.2M
$19.9M
Gary MerrillCCO
$473K
$5.4M
$671K
$6.6M
Danielle AbrahamsenCAO
$335K
$1.3M
$314K
$2.0M
The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Sep 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
STOCK Act8 disclosures of 8 on record · median 29d of the 45 allowed
Congress trades in CVLT
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
+248.1%since the saleEstimated exit price $43.68, close on Fri Feb 13, 2015Current price $152.07, close on Fri Nov 13
Feb 13, 2015
Feb 26, 2015
13d
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
The largest estimated position is in the $15,001 - $50,000 band. Estimate, as of Nov 14, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
What the filings on CVLT show and how current they are.
Which members of Congress have traded CVLT?
Josh Gottheimer, Gilbert Ray Cisneros, Jr., Lisa C. McClain and Thom Tillis disclosed CVLT transactions in the filings shown here.
Which members of Congress hold CVLT?
1 member of Congress reports a position in CVLT in the estimate we hold as of Nov 14, 2026. The estimated position belongs to Gilbert Ray Cisneros, Jr. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are CVLT trades disclosed?
Congressional disclosures took a median of 29 days, against the 45 the STOCK Act allows.